Lead commercial operations and analytics for the U.S. launch of deramiocel, a cell therapy for Duchenne muscular dystrophy.
Build and oversee commercial data ecosystem, analytics, forecasting, and field operations.
Establish scalable processes, governance, and cross-functional partnerships to drive launch readiness.
Capricor Therapeutics is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. The company is publicly traded and fosters a collaborative, mission-driven culture focused on innovation and patient impact.
Lead and execute access and reimbursement strategy aligned with BridgeBio objectives.
Manage, coach, and develop a team of Field Reimbursement Managers.
Serve as a senior subject matter expert on payer coverage, prior authorization, and reimbursement pathways.
BridgeBio is a biopharma company that develops life-changing medicines for rare diseases and unmet medical needs, using a 'moneyball for biotech' model to pool early-stage research. They value curiosity, experimentation, and ethical AI use, and foster a collaborative, family-focused culture.
Serve as regional expert on reimbursement and access for BridgeBio therapies.
Educate providers on benefits investigation, prior authorization, and appeals.
Coordinate patient support across hubs, pharmacies, and internal teams.
BridgeBio is a biopharmaceutical company pioneering a 'moneyball for biotech' approach to pool early-stage research and develop life-changing medicines for rare diseases. It values curiosity and experimentation, with small expert teams empowered to solve problems.
Build and lead the DACH commercial field team, from pre-launch education to key account management.
Own launch plans for ADH1 and achondroplasia, including local marketing and forecasting.
Partner with Medical Affairs, Market Access, and Patient Advocacy for coordinated launch execution.
BridgeBio Pharma is a biotech that uses a 'moneyball' model to fund early-stage research and develop medicines for rare diseases and genetically driven cancers. It values curiosity, experimentation, and a hands-on culture, rewarding high performers.
Lead strategic engagement with payers, PBMs, and GPO accounts to secure patient access.
Develop market access strategies and negotiate contracts, including value-based models.
Build and oversee payer account teams while collaborating across functions.
REGENXBIO is a gene therapy company pioneering treatments for rare and retinal diseases. The company fosters a collaborative, patient-focused culture with a talented team working to make a meaningful difference for patients and their families.
Serve as regional reimbursement expert, educating providers on access pathways and addressing barriers in commercial and government payer environments.
Coordinate family access and support, ensuring compliant education and seamless coordination among providers, pharmacies, and internal teams.
Act as a senior cross-functional partner, generating field insights and contributing to access strategy while mentoring colleagues.
BridgeBio pioneered a 'moneyball for biotech' approach, pooling early-stage research to reduce risk and unleash innovation for rare diseases. They value curiosity and experimentation, with a culture that defies convention and empowers problem-solvers.
Serve as field market access lead for Tab-Cel launch, educating payers and sites on coverage.
Build payer relationships to enable patient access and navigate prior authorization.
Partner cross-functionally to prepare sites for reimbursement and single-case agreements.
Pierre Fabre Laboratories is the world's second-largest dermo-cosmetics company and a leading European pharmaceutical firm. It offers a start-up culture with collaboration, innovation, and patient centricity.
Develop and maintain senior payer relationships across a ten-state Northeast territory.
Lead account strategy for 16 accounts including Highmark, Independence, Point32Health, and UPMC.
Coordinate cross-functionally to resolve access barriers and support rare disease launches.
BridgeBio is a biopharmaceutical company using a 'moneyball for biotech' model to advance early-stage research and develop rare disease treatments. It values curiosity, experimentation, and boundary-pushing, fostering a collaborative culture with respected industry minds.
Develop and execute targeted engagement strategies for key accounts and treatment centers in the Central US region.
Lead regional business planning and collaborate with cross-functional teams to drive commercial launch readiness.
Serve as primary point of contact for stakeholders, ensuring alignment with corporate goals and market access strategies.
Since 2009, REGENXBIO has pioneered gene therapy, advancing a pipeline of treatments for rare and retinal diseases. Their growing, mission-driven team collaborates to develop transformative therapies for patients in need.
Support clinical trial recruitment and site outreach, coordinating feedback with clinical teams.
Establish scientific relationships with KOLs in the Duchenne community and refine KOL mapping.
Gather scientific insights and attend medical conferences as a Medical Affairs representative.
REGENXBIO is a biotechnology company focused on developing novel AAV gene therapies for patients with rare diseases. The company has a collaborative culture driven by core values of trust, accountability, perseverance, and innovation.
Serve as the primary point of contact for patients and caregivers, providing education on disease state, therapy options, and access pathways.
Coordinate access and reimbursement, including affordability enrollment, benefit verifications, prior authorization, and site-of-care logistics.
Collaborate with internal teams and external stakeholders to remove non-clinical barriers and enhance the patient experience.
Scholar Rock is a biopharmaceutical company developing muscle-targeted therapies for spinal muscular atrophy and other rare neuromuscular diseases. It leverages a proprietary platform to create novel monoclonal antibodies, with a strong commitment to innovation and patient support.
Lead national and regional payer account management to secure broad access, reimbursement, and patient affordability.
Build and maintain relationships with payer decision makers to shape coverage, policy, and contract decisions.
Collaborate across Medical Affairs, Patient Services, and Regional Sales to execute market access strategies.
Summit Therapeutics is a biopharmaceutical oncology company focused on improving quality of life and addressing unmet medical needs. Headquartered in Miami, its global team is driven by integrity, collaboration, and commitment to people.
Develop and execute strategic access plans to streamline community access to therapies.
Serve as an in-house reimbursement expert while ensuring compliance with healthcare regulations.
Collaborate with providers, pharmacies, and stakeholders to manage access programs and support community-centered care.
BridgeBio is a biopharmaceutical company that uses a 'moneyball for biotech' model to pool early-stage research and accelerate rare disease treatments. It fosters a culture of curiosity, experimentation, and boundary-pushing, with small expert teams leading the way.
Support appropriate patient access to therapies by identifying and resolving reimbursement and access barriers.
Partner with sales, market access, patient services, and specialty pharmacies to streamline therapy initiation.
Analyze HUB and payer data to uncover systemic access gaps and implement compliant process improvements.
Cytokinetics is a specialty cardiovascular biopharmaceutical company focused on muscle biology and developing new medicines for cardiac muscle dysfunction. With over 25 years of scientific innovation, the company values integrity, diversity, and keeping patients at the center of all actions.